Intrauterine programming of the endocrine pancreas

被引:55
|
作者
Remacle, C. [1 ]
Dumortier, O. [1 ]
Bol, V. [1 ]
Goosse, K. [1 ]
Romanus, P. [1 ]
Theys, N. [1 ]
Bouckenooghe, T. [1 ]
Reusens, B. [1 ]
机构
[1] Catholic Univ Louvain, Biol Cellulaire Lab, Inst Sci Vie, B-1348 Louvain, Belgium
来源
关键词
beta-cell; diabetes; foetal development; programming;
D O I
10.1111/j.1463-1326.2007.00790.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Epidemiological studies have revealed strong relationships between poor foetal growth and subsequent development of the metabolic syndrome. Persisting effects of early malnutrition become translated into pathology, thereby determine chronic risk for developing glucose intolerance and diabetes. These epidemiological observations identify the phenomena of foetal programming without explaining the underlying mechanisms that establish the causal link. Animal models have been established and studies have demonstrated that reduction in the availability of nutrients during foetal development programs the endocrine pancreas and insulin-sensitive tissues. Whatever the type of foetal malnutrition, whether there are not enough calories or protein in food or after placental deficiency, malnourished pups are born with a defect in their beta-cell population that will never completely recover, and insulin-sensitive tissues will be definitively altered. Despite the similar endpoint, different cellular and physiological mechanisms are proposed. Hormones operative during foetal life like insulin itself, insulin-like growth factors and glucocorticoids, as well as specific molecules like taurine, or islet vascularization were implicated as possible factors amplifying the defect. The molecular mechanisms responsible for intrauterine programming of the beta cells are still elusive, but two hypotheses recently emerged: the first one implies programming of mitochondria and the second, epigenetic regulation.
引用
收藏
页码:196 / 209
页数:14
相关论文
共 50 条
  • [31] Tumors of the endocrine pancreas
    Klöppel, G
    PATHOLOGE, 2003, 24 (04): : 265 - 271
  • [32] ARTIFICIAL ENDOCRINE PANCREAS
    ALBISSER, AM
    LEIBEL, BS
    EWART, TG
    DAVIDOVAC, Z
    BOTZ, CK
    ZINGG, W
    DIABETES, 1974, 23 (05) : 389 - 396
  • [33] ENDOCRINE FUNCTION OF PANCREAS
    KRAHL, ME
    ANNUAL REVIEW OF PHYSIOLOGY, 1974, 36 : 331 - 360
  • [34] ENDOCRINE DISORDERS OF PANCREAS
    RICHARDSON, GO
    PRACTITIONER, 1968, 200 (1198) : 494 - +
  • [35] HISTOCHEMISTRY OF ENDOCRINE PANCREAS
    PETKOV, P
    ANNALES D HISTOCHIMIE, 1976, 21 (02) : 101 - 104
  • [36] GALANIN AND THE ENDOCRINE PANCREAS
    AHREN, B
    RORSMAN, P
    BERGGREN, PC
    FEBS LETTERS, 1988, 229 (02) : 233 - 237
  • [37] Endocrine tumours of the pancreas
    Verbeke, Caroline S.
    HISTOPATHOLOGY, 2010, 56 (06) : 669 - 682
  • [38] ARTIFICIAL ENDOCRINE PANCREAS
    KRUSEJARRES, JD
    JOURNAL OF CLINICAL CHEMISTRY AND CLINICAL BIOCHEMISTRY, 1979, 17 (07): : 457 - 463
  • [39] Endocrine tumors of the pancreas
    Simon, Peter
    Spileke-Liss, Elisabeth
    Wallaschofski, Henri
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2006, 35 (02) : 431 - +
  • [40] Endocrine tumours of the pancreas
    Öberg, K
    Eriksson, B
    BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2005, 19 (05) : 753 - 781